amongst them, the head of the drugmaker eli lilly. igh yesterday. here in the cnbc exclusive is john electr the company's chaim and ceo. there's so much that people want to know. what's in the pipeline, the new molecules, where we are on the patents around the world. at the same time where you are in your earnings and your profitabili profitability. in a close period, what do you say to people at a conference as you are attending today? >> well, for the first time earlier this year our industry did a broad survey of the number of medicines in development. 5,000 different medicines in some stage, clinical development, 800 of those in late stage development. last year the fda approved 39 new medicines. that's a multi--year high coming on top of 35 the year before. so i've been saying for some time that i believe we're entering a new era for this industry where we're going to see increased levels of productivity and output based on our ability, our increasing ability, to tranlate all of this great science into medicines that make a differ

at eli lilly.petition when a drug company cuts sales, that is big. accounting for 30% of the salesforce, a key weapon in competition between drug makers that will be completed by july. eli lilly hitting a 52-week high on news of cutting sales. right now down a teensy bit but still 52-week high. very good. tv networks spending a fortune to embrace the internet, but is anybody watching on their computers? tracy: gold is totally heading into bear market territory, so what should your next move be? the dow down 31 points, look at that, biotech up about 4%. we will be right back. all stations come over to mission a for a final go. this is for real this time. step seven point two one two. rify and lock. command is locked. five seconds. three, two, one. standing by for capture. the most innovative software on the planet... dragon is captured. is connecting today's leading companies to places beyond it. siemens. answers. dennis: almost 90% of viewers watch tv with one second screen device in hand. the tv n

check out eli lilly. it beat the street estimates with an earnings report. the special status of its blockbuster anti-psychotic drug xyprexa. today saying it was a lower tax rate, research credit, one-time payment that did the trick. oigs, it was the usual cost-cutting. yeah, wow the lemmings are saying today it just won't cut it. there's got to be some growth, a scintilla of growth. and the flat revenues, there was none to be had. >> the house of pane! >> the shareholders and the other drug stocks turned into lemmings, they immediately dame for abvi, for bristol-myers, pfizer the group considered, suddenly had hair on it. the technical term for -- oh, boy, things aren't so crystal as i thought. bristol-myers decide to be greedy. i have a thing going for these lemmings. it's about time somebody took profits in these drug stocks, speaking of profit, how about the mass moving amgen today. the lemings are holding the power over that cliff, down over 7 points, the worst first time king in three years. why not? the first revenue missed about that length of time.

check out eli lilly. the blockbuster anti-psychotic drug, but a patent cliff, that's one thing. lcemming cliff is another. one-time payment, otherwise the strength was off from the usual cost cutting. yeah. and, well, cost cutting, the lemmings are saying today it just won't cut it. there's got to be some growth. a cint ichilla of growth. the other stocks turned into lemmings that came from bristol-myers, pfizer, suddenly had hair on it. the tactical term for, oh, boy, things are not as clean as i thought. after deciding not to be greedy, i got a little thing going for these lemmings. it's about time somebody got some profits from these products. how about amgen today. wow, the lemmings are really willing to pile over that cliff. down 7 points, and why not? this quarter marked the first loss for amgen and they could be losing steam. i'm tested to blame this one on the lance armstrong confession and the end of doping by athletes. facetious. in the meantime, the host of the pipeline are not contributing anything new. there's too much hope in amgen. it might not be done going down,

eli lilly up almost 23%. but merck has lagged. it's advanced far less. 6% over the same period.ok, it deserves it. there has been a series of stumbles and negative headlines that is just as long as my arm. average trade of 14 times earnings. many of them have much of higher price to earning multiples than merck and even the lilies and the pfizers. granted, there are reasons why merck, one of the largest drug companies on erparth, has been lag effort. let's go through. in december they had stop u.s. development of a cholesterol drug after bad trial results and had to pull the drug overseas and it looked like a real winner. in february, we found out that merck planned to delay some new osteoporosis drugs from the fda which pushed back the company's new drug application next year. another winner. and last month ugly headlines about how a class of type two diabetes drugs, two blockbuster drugs for merck might cause a risk for pan create titus and cancer, mostly fatal. although those stories were mostly sound and fury, signifying nothing. those risks have been known about for years.

eli lilly set to cut 1,000 jobs as the company faces competition from generic drugs.illy's blockbuster cymbalta loses patent protection later this year. >>> facebook starts selling its new home app for htc smartphones today. your facebook home page will be the first thing you see when you turn on your phone. dara, back to you. >> thank you, seema. >>> good news if you're hitting the road. gas prices continue to fall. aaa says the national average is $3.56, down from $3.70 a month ago. >>> blackberry shares took a hit thursday after reports of an abnormally high return rate and dwindling sales for its new blackberry z-10. the company calls the allegations absolutely false. >>> if you're wondering what the winklefox twins are up to, wonder no more. famous for suing mark zuckerberg, they're now venture capitalists. and major big-coin investors. they say they own about $11 million worth of the currency. >>> mcdonald's has killed a regional subway ad that pokes fun at mental illness. it reads "you're not alone. millions of people love the big mac," parodying a mental healt

investors took a ho hum view of mostly positive earnings reports from before the bell about boeing, eli lilly, and others. the dow was down, dragged by a 6% decline after proct & gamble lowered its outlook for the year. the cfo described the economy as challenging, he confirmed his company's 2013 outlook. nasdaq and the s&p 500 both closed a tiny fraction higher. >>> encouraging housing news. applications for new mortgage loans rose 1% last week as rates on those mortgages kicked lower for a fifth week in a row. most of the new applications came from current homeowners refinancing existing loans. but at a cheaper rate. >>> many of those current homeowners are staying right where they are and taking advantage of lower mortgage rates. many would be home buyers are snapping up newly constructed houses, almost as quickly as they're being built. and that's driven some home builders to do something we haven't seen since the housing bust. building houses first on spec and then trying to sell them. diana olick has more on this old new trend. >> reporter: steven paul says he should have no problem sel

. >>> eli lilly is set to cut about 1,000 jobs as companies face competition from generic drugs.lta loses patent protection later this year. >>> facebook wants to be your digital home on the go. the social networking site starts selling its new home app for htc smartphones today. your facebook home page will be the first thing you see when you turn on your phone. back to you. >> seema, thanks for that opinion. >>> a little good news if you are hitting the road. gas prices continue to fall. aaa says the national average is $3.56 a gallon. that's down from $3.70 a month ago. blackberry shares took a hit thursday after reports of an abnormally high return rate and dwindling sales for its new blackberry z10. the company says those allegations are absolutely false. >>> and if you are wondering what the winklevoss twins are up to, wonder no more. famous for suing mark zuckerberg for allegedly stealing the idea for facebook. they are now venture capitalists and major big coin investors. they told "the new york times" they own about $11 million worth of the digital currency. >>> a mea cu

attacking the ban on fracking and cut back right now under the investor state system and now after eli lilly is attacking can his entire patent system not in its courts but in a private corporate tribunals demanding taxpayer money what's different there we go tell us what's different laurie is the u.s. in the e.u. are not developing countries our courts are at the top of the list of courts that are reliable function well and international lists of those we are not having scant property rights here so both as far as the substantive rights of investors and the ability adjudicate fairly are property rights in courts the notion of having a parallel system on top of our constitution our courts that is just for foreign corporations to raid our treasury is obscene and it gets rid of the whole notion that what that investor state system is about is kind of the kind of accommodation for a developing country investment this is too rich country box but i think the thing here that sort of scares me is sort of a crowd out effect of democratically elected state legislatures or government lower you know na

eli lilly stock down 0.5% in frankfurt.y reportedly hired blackstone to advise it on financing. options could include selling a minority stake. the company has already contacted several private equity firms about a possible investment. on sunday, bill akman said they're willing to pup up more. jcpenney in frank first up 2%. >>> now, away from the corporates to the greens, round one of the masters is in the books with the weather cooperating for the players. tiger woods seen here shot an opening round 70 to beat 2 under par. he's won three times before. 14-year-old jan manwuan, this birdie meant he ended at one over. fred couples is one back from sergio gar seen ya, tied with the lead from scott leishman at six under. >>> right. that's where we stand on the scores. brian now joins us from augusta. it's early dawn there, brian, but they'll cut the greens already if they're not doing that right now. great day one from augusta. what's the buzz around the tournament from a financial perspective this year? the equity market has b

raising their price targets of several of these names including pfizer, merck, johnson and johnson, eli lillyyers, we remain positive on this group on the pharmaceutical group. valuation. at this anti we should talk about the fact that pfizer has positive reviews. breast cancer patients. late stage trials. that is obviously great news for pfizer and also for breast cancer patients. liz: i don't know. i heard that and thought, why isn't the stock moving higher? i guess this is all just talk. they cute. in the annual shareholder letter from the jamie dimon he flat out apologizes for the london will fiasco, but that is up the news that charlie gasparino has been regius her to break down what no one else noticed. >> reporter: so myopic refocused on his medical with the london whale. liz: by a pick and mako puppy recall the s.a.t. board. >> reporter: i did well on my sats. liz: what did you make? and dying to know. >> reporter: had no. i can remember. anyway. i took the gop's to get it. liz: i took the gre as well. so interesting enough, took a lot of shots that policy makers to i found it fascina

companies in terms of dollars being invested in new therapies to fight alzheimer's, merck, pfizer eli lillythe way, you might wonder why we bumped in with apple shares? because they have turned negative. >> quite a slide, pretty much wiping out almost all the run it had right at the open. >> here on "street signs" only people that you actually want to link with. one at a time. it's called link me. matt is here. you are wearing set device. >> i'm wearing said device. >> am i wrong in not calling that watch? >> you are wrong. >> what is that? >> this is a wristband action a brace lett you can get your text messages on, facebook and twitter feeds. >> can you take it off? >> sure. >> it's kind of cool. it basically actually looks like a scrolling news ticker. >> very light, three ounces. >> there you go, so if you and i were linked, you can sigh, dude, let's watch the knicks game, and it would come like that? >> it would come like that, the battery life is over two weeks, packs quite a heavy punch. doesn't look all that much at first, but when you get into the science and technology. >> sell it

companies have -- eli lilly not doing much better. i can't help but see this as a little bit of a kind of gift to big pharma. i think it's about generating jobs and money and that's what obama talked approximate. >>> we're going to stay on that topic. i want to talk about alzheimer's, what we already know and maybe sam will take the brain apart a little bit. i think there's something to be said about this shift in priorities. when we say alzheimer's, it tracks the boomers. there's a lot of them and now they're aging. when we come back. we're all set to bundle your home and auto insurance together. i'll just press this, and you'll save on both. [bell dings] ladies and gentlemen, boys and girls, llllet's get ready to bundlllllle... [ holding final syllable ] oh, yeah, sorry! let's get ready to bundle and save. now, that's progressive. oh, i think i broke my spleen! i need a new recruit! dawn? you won't last. [ female announcer ] a drop of dawn has active suds that stay stronger longer, so you can clean 2x more greasy dishes. dawn does m

i think that at a time when stocks like general mills and eli lilly keep roaring ahead and ahead therenames to, find stocks left behind. but aren't doing as badly as feared, and start buying them. that fits ross stores and more importantly, puts -- fits bed, bagged and beyond to a t. one more thought. if bed bath doesn't go higher and the cash flow keeps gushing, this is a natural for a private equity buyout. company isn't keeping pace with the retail growth stores. why? i've got to tell you, if i were them i would say enough of this. enough of the public markets. i'll go private. let's get bed, bath and beyond a chance to approach the market in a more bountiful and forgiving time. something to think about if this stock ever goes back to the depressed levels where it was hated by the analysts and became a pin i can't tella for short-sellers everywhere. not there yet. down a couple bucks. buy, buy, buy. stick with cramer. [ male announcer ] there are people who find their own path. and never back down. who believe the american dream doesn't just happen, it's something you have to work f

better than expected profits at eli lilly. it's better than expected profits, but it's down, not much. 1% though. disappointing profit in the furniture maker ethan allen. look at that. down it goes. 8% lower. back to the big board. we're expecting 20, maybe 30 points up. didn't get it. 11 points higher. and now we've got it. at&t, that's the big loser. down 4% it's a dow stock and that's why the dow u-dow is not up the 20, 30 points we thought it was going to be. we rollebsp you'scksn qkay(3 c1 & check the other markets. and oil $89 a barrel and gold is a little higher, too. and i say the public's lost trust in wall street. yesterday's flash crash does not help. does dr. keith ablow. he gets inside your head. he's going to do that next, okay? clients are always learning more to make their money do more. (ann) to help me plan my next move, i take scottrade's free, in-branch seminars... plus, their live webinars. i use daily market commentary to improve my strategy. and my local scottrade office guides my learning every step of

it doesn't matter right now whether it's eli lilly, pfizer.oup is the best of the breed because they have the most upside but i think pfizer got that run up to 31. this diabetes that they're working with merck right now is outstanding. i think both of them are going to do very well because of it. >> "welcome to twitter. the sxwlit team is happy to see you here." hi, dave barger. seth tweets, "i'm a close friend of guy adami and he'll vouch for me that you and i belong together. dinner tonight, xoxo." >> and she's finally off twitter. >> that was a short run. >> shortest stint ever. thank you for the invitation, but i've got plans. is that nice? >> no, it's not nice. you say i'd love to. where do you want to go? >> you just have to be careful with these things. he has asked nicely. >> that's true. the xoxo was a nice touch too. nice loving touch. coming up next, we've got your first move tomorrow. straight ahead. >>> it's >>> it's easy to get stressed out during earnings season but don't let all the headlines give you a headache. what you knee

eli lilly hitting wires this morning. earnings of 1.14 a share. ahead of 1.05 the street expected.evenues are in line. coming up, learning from the pros. we'll talk golf investing. that's next. there are more similarities than you might think. green is the word of the day. you can see joe is out there right now. first as we head to a break, check out the dollar. stay tuned. we have a lot more. joe will give us a lesson on the tee this morning. ]xuñ >>> welcome back. we're kicking off our new learning from the pro series this week. today we take to the putting greens to pair up investing pros with golfing pros and hear their top tips and strategies when approaching their craft. here with us on the green, dan is a chief investment officer and a golf professor who is unfortunately going to try to help with my putting. this entire series, i need to divorce my own feelings about this sport because i feel fatalistic. if investing was the same as golf, i would put everything in t-bills. i just asked what is the definition of insanity and is that what they say? doing the same thing over an

eli lilly is laying off 1000 people from its sales force nationwide.of a restructuring process to cut costs and better equip the company for competition with generic medications. the cuts which account for 30% of the drugmaker's sales force should be finished by july. >>> german investor jab is buying, de master blenders for $9.8 billion. de master blenders which has a strong position in europe was spun off from sara lee last year. >>> american workers can't entirely blame the new health care reform for lost insurance coverage according to the robert wood johnson foundation. employer sponsored health insurance has fallen 10% in the past decade. employers have been dropping insurance coverage in an effort to counter the soaring cost of health care that is the latest from the fox business network, giving you the power to prosper lori: blackberry shares are bouncing back up over 3% since yesterday. the company fights back against one analyst's claims that z10 returns are exceeding sales. dennis kneale on this battle. he is fired up. melissa: you are fired

eli lilly did not report a great number, but the stock held in. the great anomaly, of course, is my absolute favorite stock of the moment which is johnson & johnson. this fellow comes in, gorski, how about the diaspora of j & j. did you see that? >> i did. >> i think it was up over 50% this year if i'm not mistaken. if someone wanted to take it over it would have been a smart move. >> by the old management team they're all out and the chairman at avon. >> i do think they're combinations of yield. i heard barbara ryan won yesterday. she's always fabulous on scott wapner's judges' show. merck is a great company that can restructure and has a lot of things in the pipe. this group is charmed. the stock market is not a hall of justice. it is not a jury that tries to get at the truth. the stock market embases what's hot, it always has. >> you called it a harsh judging machine the other day when it came to apple. >> yes. >> i know many people think it's like law and order and you get in front of a judge and the right thing happens and you're on thin ice.